Business
Bell Potter just upgraded the target price on ASX healthcare stock
Image source: Getty Images
Broker Bell Potter has issued a new report on ASX healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU).
It has maintained its buy rating and also increased its target price.
Neuren Pharmaceuticals is a biopharmaceutical company specialising in developing new…
Continue Reading
-
Noosa News16 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News16 hours agoNon-compliance, human error led to $2m Noosa Council fraud
-
General23 hours agoCoalition ‘flabbergasted’ by Labor’s response to calls for royal commission into antisemitism
-
Noosa News18 hours agoGold Coast motorcyclist injured after road rage collision on M1